PharmaCyte Biotech, Inc. Common Stock
$0.738
USD
Last updated on --.
24h volume82.94K
24h highest0.71600 USD
24h lowest0.71600 USD
24h Price movement+1.57%
PMCB recent prices
24 Hours
+1.57%+$0.0114
30 days
+0.68%+$0.005
60 days
+4.36%+$0.0308
90 days
-1.99%-$0.015
Key data
Previous close0.72660 USD
Market cap8.96M USD
Volume82.94K
P/E ratio--
Dividend yield (TTM)0.02%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.70000 USD
Net income (FY)-3.28M USD
Revenue (FY)--
Last report dateMar 17, 2026
About PharmaCyte Biotech, Inc. Common Stock
HeadquartersLAS VEGAS
Employees (FY)2.00
Net income per employee (FY)-1.64M USD
Listed onNasdaq
PMCB conversion tables
 |  |
|---|---|
| 0.5 PMCB | 0.369 USD |
| 1 PMCB | 0.738 USD |
| 5 PMCB | 3.690 USD |
| 10 PMCB | 7.380 USD |
| |
|---|---|
| 0.5 USD | 0.67751 PMCB |
| 1 USD | 1.355 PMCB |
| 5 USD | 6.775 PMCB |
| 10 USD | 13.55 PMCB |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PMCB is trading at $0.738, +1.57% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PMCB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PMCB is currently trading at $0.738, +1.57% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PMCB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PMCB's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PMCB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PMCB's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
PharmaCyte Biotech, Inc. Common Stock's market cap is currently 8.96M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume82.94K
24h highest0.71600 USD
24h lowest0.71600 USD
24h Price movement+1.57%
Start trade with PMCB Perpetual
Sign up to trade